The HistoOncoImmune Methodology

Read our Feb 2016 paper in Expert Reviews: Challenges & Perspective of Immunotherapy Biomarkers. In this review, Christopher Ung and Mark Kockx discuss the challenges of PD-L1 IHC and potential solutions to harness morphology and molecular information from the tumor microenvironment.

Challenges & Perspectives of Immunotherapy Biomarkers & The HistoOncoImmune™ Methodology by Christopher Ung & Mark M. Kockx

To cite this article: Christopher Ung & Mark M. Kockx (2016) Challenges & Perspectives of Immunotherapy Biomarkers & The HistoOncoImmune™ Methodology, Expert Review of Precision Medicine and Drug Development, 1:1, 9-24

To link to this article: http://dx.doi.org/10.1080/23808993.2016.1140005